Lenzing Biocel Paskov made a net profit of CZK 1,111 mil with revenues of CZK 5,285 mil in 2019, down by 21.6% and up by 0.683%, respectively, compared to the previous year.
This translates into a net margin of 21.0%. Historically, between 2007 and 2019, the firm’s net margin reached a high of 29.1% in 2017 and a low of -2.62% in 2012. The average net margin in the last five years amounted to 24.0%.
On the operating level, the EBITDA margin reached 36.7% and EBIT amounted to 29.0% of sales in 2019.
You can see all the company’s data at Lenzing Biocel Paskov profile, or you can download a report on the company in the report section.
Helgi Library 
